Drug Trial Radar · NCT00000919
A Study to Evaluate Various Combinations of Anti-HIV Medications to Treat Early HIV Infection
Last checked: Nov 19, 2026Latest source record: Jun 7, 2012 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
900
Actual
Start
Not stated
Primary completion
Not stated
Study completion Nov 2002
Sponsor
- Sponsor type
- NIH
- First posted
- Aug 31, 2001
Design
- Study type
- Interventional
- Phase
- Not applicable
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- All sexes, from 13 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effectiveness of various combinations of anti-HIV drugs in HIV-positive men and women. Patients receive specific combinations of 3 or 4 of the following 6 drugs: didanosine (ddI), stavudine (d4T) efavirenz (EFV), nelfinavir (NFV), lamivudine (3TC), or zidovudine (ZDV). Anti-HIV therapy is effective in preventing the spread of HIV in the body. However, patients often experience unpleasant side effects and have difficulties following the dosing schedule. This study looks for combinations of anti-HIV drugs ("cocktails") which will be the most effective with the fewest problems.
Conditions
- HIV Infections
Interventions
Indinavir sulfateDrug
Lamivudine/ZidovudineDrug
RitonavirDrug
HydroxyureaDrug
Abacavir sulfateDrug
AmprenavirDrug
Nelfinavir mesylateDrug
EfavirenzDrug
LamivudineDrug
StavudineDrug
ZidovudineDrug
DidanosineDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
80 sites in 3 countries. Site status is shown where the registry gives one.
Univ of Alabama at Birmingham
Birmingham, Alabama
Univ of Southern California / LA County USC Med Ctr
Los Angeles, California
UCLA CARE Ctr
Los Angeles, California
Willow Clinic
Menlo Park, California
Univ of California / San Diego Treatment Ctr
San Diego, California
San Francisco AIDS Clinic / San Francisco Gen Hosp
San Francisco, California
San Francisco Gen Hosp
San Francisco, California
Santa Clara Valley Med Ctr / AIDS Community Rsch Consortium
San Jose, California
Marin County Specialty Clinic
San Rafael, California
San Mateo AIDS Program / Stanford Univ
Stanford, California
Stanford Univ Med Ctr
Stanford, California
Harbor UCLA Med Ctr
Torrance, California
Univ of Colorado Health Sciences Ctr
Denver, Colorado
Georgetown Univ Hosp
Washington D.C., District of Columbia
Howard Univ
Washington D.C., District of Columbia
Univ of Miami School of Medicine
Miami, Florida
Emory Univ
Atlanta, Georgia
Emory Hemo Comp Evaluation Clinic / East TN Comp Hemo Ctr
Atlanta, Georgia
Univ of Hawaii
Honolulu, Hawaii
Northwestern Univ Med School
Chicago, Illinois
Cook County Hosp
Chicago, Illinois
Rush Presbyterian - Saint Luke's Med Ctr
Chicago, Illinois
Indiana Univ Hosp
Indianapolis, Indiana
Division of Inf Diseases/ Indiana Univ Hosp
Indianapolis, Indiana
Methodist Hosp of Indiana / Life Care Clinic
Indianapolis, Indiana
Univ of Iowa Hosp and Clinic
Iowa City, Iowa
Charity Hosp / Tulane Univ Med School
New Orleans, Louisiana
Tulane Med Ctr Hosp
New Orleans, Louisiana
Tulane Univ School of Medicine
New Orleans, Louisiana
State of MD Div of Corrections / Johns Hopkins Univ Hosp
Baltimore, Maryland
Harvard (Massachusetts Gen Hosp)
Boston, Massachusetts
Boston Med Ctr
Boston, Massachusetts
Beth Israel Deaconess - West Campus
Boston, Massachusetts
Univ of Minnesota
Minneapolis, Minnesota
St Louis Regional Hosp / St Louis Regional Med Ctr
St Louis, Missouri
Univ of Nebraska Med Ctr
Omaha, Nebraska
SUNY / Erie County Med Ctr at Buffalo
Buffalo, New York
Beth Israel Med Ctr
New York, New York
Manhattan Veterans Administration / New York Univ Med Ctr
New York, New York
Chelsea Ctr
New York, New York
Showing 40 of 80 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.